This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ong ATL, Daemen J, van Hout BA, Lemos PA, Bosch JL, Van Domburg RT, Serruys PW.Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry. European Heart Journal 27: 2996-3003, No. 24, Dec 2006
Rights and permissions
About this article
Cite this article
Unrestricted drug-eluting stent use not worth it. Pharmacoecon. Outcomes News 522, 8 (2007). https://doi.org/10.2165/00151234-200705220-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705220-00022